氟对大鼠骨代谢的影响

目的 观察氟对大鼠骨代谢的影响,探讨氟骨症的发病机制.方法 Wistar雄性大鼠80只,体质量80～100 g.将大鼠按体质量随机分为4组:对照组(饮用自来水),低剂量组(NaF,50 mg/L),中剂量组(NaF,100 mg/L),高剂量组(NaF,150 mg/L),每组20只.饲养12周,乙醚麻醉处死大鼠,观察大鼠氟斑牙发生率;股动脉取血,放射免疫法测定血清骨钙素(BGP)、甲状旁腺激素(PTH)、降钙素(CT);比色法测定血清碱性磷酸酶(ALP)、酸性磷酸酶(ACP).结果大鼠氟斑牙检出率组间比较差异有统计学意义(x2=82.81,P＜0.01);其中低(80%,16/20)、中(100%,20/20)、高剂量组(100%,20/20)与对照组(0,0/20)比较差异有统计学意义(x2值分别为22.67、40.00、40.00,P均＜0.01).大鼠血清BGP、PTH、CT组间比较差异有统计学意义(F值分别为38.614、20.778、3.023,P＜0.01或＜0.05);但ALP、ACP组问比较差异无统计学意义(F值分别0.609、2.895,P均＞0.05).血清BGP:低、中、高剂量组[(19.60±12.79)、(33.41±10.81)、(39.46±9.51)mg/L]高于对照组[(7.35±3.22)mg/L,P均＜0.01],中、高剂量组高于低剂量组(P均＜0.01);血清PTH:低、中、高剂量组[(72.27±25.38)、(67.80±12.01)、(106.52±36.37)pmol/L]高于对照组[(47.08±9.22)pmol/L,P均＜0.01],高剂量组高于低、中剂量组(P均＜0.01);血清CT:中、高剂量组[(13.39±2.07)、(15.05±4.77)pmol/L]低于对照组[(26.06±28.31)pmol/L,P均＜0.05],也低于低剂量组[(24.49±14.10)pmol/L,P＜0.05].结论氟影响大鼠的骨代谢,BGP、PTH、CT在氟骨症发病中起着重要的作用.

Effect of fluoride on bone metabolism in rats

Objective To study the effect of fluoride on bone metabolism in rats, and to understand the mechanism of pathogenesis of skeletal fluorosis. Methods A total of 80 Wistar rats were randomly divided into 4 groups that included control group (distilled water), low-dose group(NaF, 50 mg/L), medium-dose group (NaF,100 mg/L) and high-dose group(NaF, 150 mg/L), respectively. After being bred for 12 weeks, the rats were put to death (etherization). Incidence of dental fluorosis was estimated, and serum was collected. Radioimmunoassay was employed to detect the levels of osteocalcin (BGP), parathyroid hormone (PTH) and calcitonin (CT), respectively.Colorimetry method was employed to determine the levels of alkaline phosphatase (ALP) and acid phosphatase (ACP). Results Incidence of dental fluorosis between the four groups was significantly different statistically(x2 =82.81 ,P ＜ 0.01 ). The incidence was significantly different(x2 = 22.67, 40.00, 40.00, all P＜ 0.01 ) between low-dose ( 80%, 16/20), medium-dose ( 100%, 20/20), high-dose groups ( 100%, 20/20) and control group (0,0/20),respectively. Serum levels of BGP, PTH, CT were significantly different between the groups(F = 38.614, 20.778,3.023, P ＜ 0.01 or ＜ 0.05). There was no significant difference between the four.groups of ALP and ACP in serum (F = 0.609,2.895, all P ＞ 0.05 ). Serum BGP in low-dose, medium-dose and high-dose groups[ ( 19.60 ± 12.79),(33.41 ± 10.81 ), (39.46 ± 9.51 )mg/L, respectively] was significantly higher than that of the control group[ (7.35 ± 3.22)mg/L, all P ＜ 0.01 ]. Serum PTH in low-dose, medium-dose and high-dose groups[ (72.27 ± 25.38), (67.80 ± 12.01), (106.52 ± 36.37)pmol/L] was significantly higher than that of the control group[(47.08 ± 9.22)pmol/L,all P ＜ 0.01 ]. Serum PTH of the high-dose group was significantly higher than that of the low-dose and the mediumdose groups(all P ＜ 0.01 ). Serum CT in medium-dose and high-dose groups[ ( 13.39 ± 2.07), ( 15.05 ± 4.77)pmol/L ] was significantly lower than that of the control group[ (26.06 ± 28.31 ) pmol/L, all P ＜ 0.05 ] and also significantly lower than that of the low-dose group [ (24.49 ± 14. 10) pmol/L, all P ＜ 0.05 ]. Conclusions Fluoride affects bone metabolism in rats, BGP, PTH and CT play a key role in the pathogenesis of skeletal fluorosis.